Nureca Limited
Others · NSE
↓ 51.8% vs fair value
52W Low
₹204
+33.3% from low
52W High
₹343
-20.7% from high
Valuation Gauge
Current Price
₹272
Fair Value
₹179
Fair Value Analysis
₹179
Based on balance sheet strength analysis and earnings growth potential for Others sector companies | CAUTION: ROCE declining (latest 27.1%) — returns on capital are falling; verify this isn't a value trap. | Growth capped at 6.1% (ROE 5.3%×1.15) — historical CAGR exceeds sustainable rate or COVID period unverifiable.
Balance Sheet Value
50% weight
Growth Valuation
50% weight
Price vs Market
Shareholding Pattern
Stock Health Score
Mixed Signals
Profitability
ROE of 5.3% is below the Others sector benchmark of 15%
Debt & Leverage
D/E ratio of 0.0x is well within the Others sector norm of 0.8x — strong balance sheet
Valuation vs Peers
P/E of 25.1x trades at a 37% discount to Others sector median (40x) — attractively valued
Cash Flow
Negative FCF of ₹-23 Cr — company is consuming more cash than it generates
Earnings Growth
5yr EPS CAGR of -73.4% — severe earnings decline
Dividend
No dividend — typical for growth-stage companies
Company Health Timeline
10-year financial health at a glance
Sentiment Trend — Last 30 Days
Historical Returns
Key Ratios & Growth
FCF Yield
-4.3%
Free cash flow / market cap
Revenue Growth (YoY)
+49.8%
Year-on-year revenue change
Profit Growth (YoY)
-233.2%
Year-on-year PAT change
Operating Cash Flow
₹-19 Cr
TTM cash from operations
Key Financials
EPS (TTM)
₹10.8
P/E Ratio
25.1x
P/B Ratio
1.3x
ROE
5.4%
ROCE
0.9%
Debt / Equity
0.03x
Beta
0.66
Div Yield
—
FCF (Cr)
₹-23 Cr
Revenue (Cr)
₹110 Cr
EPS Growth 5Y
-73.4%
Mkt Cap (Cr)
₹273 Cr
52W High
₹343
52W Low
₹204
Book Value/Share
₹208.6
Financial History
| Period | Revenue | Op Profit | OPM% | PAT | EPS |
|---|---|---|---|---|---|
| TTM | ₹143 Cr | ₹7 Cr | 5.0% | ₹11 Cr | ₹10.82 |
| 2025-03-31 | ₹110 Cr | ₹-8 Cr | -7.0% | ₹1 Cr | ₹0.85 |
| 2024-03-31 | ₹92 Cr | ₹-10 Cr | -11.0% | ₹-2 Cr | ₹-1.79 |
| 2023-03-31 | ₹111 Cr | ₹-15 Cr | -13.0% | ₹-8 Cr | ₹-8.25 |
| 2022-03-31 | ₹256 Cr | ₹56 Cr | 22.0% | ₹45 Cr | ₹44.96 |
| 2021-03-31 | ₹213 Cr | ₹62 Cr | 29.0% | ₹46 Cr | ₹46.37 |
| 2020-03-31 | ₹99 Cr | ₹10 Cr | 10.0% | ₹6 Cr | ₹6400.00 |
| 2019-03-31 | ₹62 Cr | ₹9 Cr | 15.0% | ₹6 Cr | ₹6230.00 |
Compounded Growth Rates
Sales Growth
Profit Growth
EPS Growth
Peer Comparison
Others| Stock | Price | Fair Value | MoS% | P/E | ROE | Signal |
|---|---|---|---|---|---|---|
AVRO INDIA LIMITED | ₹10.3 | ₹75.8 | +86.5% | 38.2 | — | UNDERVALUED |
Magnum Ventures Limited | ₹19.8 | ₹119.4 | +83.4% | — | -1.6% | UNDERVALUED |
DCM Shriram Industries Limited | ₹41.7 | ₹196.1 | +78.7% | 3 | 12.6% | UNDERVALUED |
Star Paper Mills Limited | ₹141.5 | ₹657.4 | +78.5% | 5.6 | 44.2% | UNDERVALUED |
HB Stockholdings Limited | ₹60.5 | ₹281.1 | +78.5% | 3.8 | 13.1% | UNDERVALUED |
Balkrishna Paper Mills Limited | ₹18.7 | ₹80.6 | +76.8% | 3.1 | 26.1% | UNDERVALUED |
Heads UP Ventures Limited | ₹7.1 | ₹28.8 | +75.3% | 3.9 | — | UNDERVALUED |
Credo Brands Marketing Limited | ₹88.5 | ₹305.8 | +71.1% | 10.9 | 16.4% | UNDERVALUED |
Institutional Activity
Bulk deals, block deals, short selling & delivery volume — NSE data
Insider Trading
Share this Stock
Download card · Share on WhatsApp
Share on WhatsApp, Twitter, or any group — each share brings new users to Veritas Quant
Analyst Note
4d ago
Nureca Limited is overvalued by ₹272 compared to its fair value of ₹179.22, indicating a margin of safety of -51.5%. The company's return on equity (ROE) has contracted to 5.3%, while its return on capital employed (ROCE) has deteriorated to 0.9%. Sentiment has turned bearish over the last week, despite a bearish 30-day trend. This stock suits a conservative investor looking for value opportunities.
What is Dalal Street saying?
r/IndiaInvestments · r/Dalal_Street_Investments · r/IndianStockMarket
No Reddit mentions found yet for NURECA.
Telegram Channels
ET Markets · CNBC TV18 · Moneycontrol · Zee Business · NDTV Profit
No Telegram mentions found yet for NURECA.
Search Interest
Google Trends · India · Last 90 days"Nureca"
Interest score (0 = low, 100 = peak)
90-day trend
StockTwits
What traders are saying right now
No StockTwits activity found for NURECA.
Technical Pulse
Plain English — no jargon
Not enough price history to assess trend.
RSI is 51 — neutral momentum, neither overbought nor oversold.
Below 20-day but above 50-day average — short-term weakness but medium trend intact.
Trading significantly above fair value. Unless you believe the business has permanently re-rated, the risk-reward is unfavorable here.
Nureca Ltd is Rated Sell by MarketsMOJO - Markets Mojo
Nureca Ltd Upgraded to Sell by MarketsMOJO on Technical Improvements - Markets Mojo